Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Exclusion Criteria

• •Patients for whom treatment with triptorelin pamoate or leuprolide acetate is contraindicated;
• •Known hypersensitivity to triptorelin, leuprolide or any other GnRH or luteinizing hormone releasing hormone (LHRH) agonists, or GnRH or LHRH;
• •Clinically significant systemic disease or condition that would, in the investigator's opinion, lead to undue risk following administration of either triptorelin or leuprolide;
• •History of alcohol/drug abuse within the past year;
• •History of significant medical problems that may confound the outcome of this study;
• •Requires concomitant medications that may affect study assessments (e.g., topical medications used for pretreatment of injection site pain);
• •Participated in another investigational drug study within 30 days
• •Judged by the investigator to be unsuitable for enrollment in this study for any reason